Endocrine Reviews 19 (2): 144-172
Copyright © 1998 by The Endocrine Society
The Endocrine Effects of Nonhormonal Antineoplastic Therapy
Sai-Ching Jim Yeung,
Alice Cua Chiu,
Rena Vassilopoulou-Sellin and
Robert F. Gagel
Joint Baylor College of Medicine-The University of Texas M. D.
Anderson Cancer Center Endocrinology Fellowship Program (S.-C.J.Y.,
A.C.C.); and Section of Endocrinology (R.V.-S., R.F.G.), Department of
Medical Specialties, The University of Texas M. D. Anderson Cancer
Center, Houston, Texas 77030
- I. Introduction
- II. Disorders of Glucose Metabolism
- A. Diabetes mellitus
- B. Glycosuria and ketonuria
- III. Disorders of Free Water Clearance
- A. Syndrome of inappropriate ADH (SIADH)
- B. Nephrogenic diabetes insipidus
- IV. Disorders of Mineral Metabolism
- A. Hypocalcemia
- B. Hypercalcemia
- C. Hypomagnesemia
- V. Metabolic Bone Diseases
- A. Osteoporosis
- B. Rickets or osteomalacia
- VI. Thyroid Disorders
- A. Serum thyroid hormone-binding protein abnormalities
- B. Hypothyroidism
- C. Thyrotoxicosis
- D. Thyroid neoplasm
- VII. Disorders of Lipid Metabolism
- A. Hypertriglyceridemia
- B. Hypercholesterolemia
- VIII. Adrenal Dysfunction
- A. Primary adrenal insufficiency
- B. Secondary adrenal insufficiency
- IX. Disorders of GH Secretion and Growth
- A. GH deficiency
- B. Growth retardation
- X. Reproductive Dysfunction
- A. Reproductive dysfunction due to hypothalamic-pituitary damage
- B. Gonadal toxicity
- XI. Prevention and Surveillance of Endocrine Side Effects
- A. Pediatric screening
- B. Adult screening.
Copyright © 1998 by The Endocrine Society